Abstract
In conclusion, it was the differential responses of slow and rapid acetylators to procainamide therapy that gave the initial clues that acetylprocainamide might be a safer drug than procainamide. So far, the experience with acetylprocainamide has been encouraging.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Acecainide / adverse effects
-
Acecainide / pharmacology*
-
Acecainide / therapeutic use
-
Acetylation
-
Animals
-
Arrhythmias, Cardiac / drug therapy
-
Isomerism
-
Kinetics
-
Procainamide / analogs & derivatives*
-
Procainamide / metabolism